First day of trading in Ectin Research
Today is the first day of trading in Ectin Research, a pharmaceutical company that specializes in research and development of drug candidates, primarily for bladder cancer.Ectin Research was founded in 2013 and is active in biotechnology. The company specializes in the research and development of drug candidates. The research is focused on developing drugs that aim to eliminate cancerous tumors in patients, with the greatest focus on the treatment of bladder cancer. In addition, the company intends to develop drugs for the treatment of breast, colorectal, and prostate cancer cells. “We